Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis
View ORCID ProfileBenedicto Crespo-Facorro, View ORCID ProfileMiguel Ruiz-Veguilla, View ORCID ProfileJavier Vázquez-Bourgon, View ORCID ProfileAna C. Sánchez-Hidalgo, View ORCID ProfileNathalia Garrido-Torres, View ORCID ProfileJose M. Cisneros, View ORCID ProfileCarlos Prieto, View ORCID ProfileJesus Sainz
doi: https://doi.org/10.1101/2020.12.05.20244590
Benedicto Crespo-Facorro
aDepartment of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain
bSpanish Network for Research in Mental Health (CIBERSAM), Sevilla, Spain
Miguel Ruiz-Veguilla
aDepartment of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain
bSpanish Network for Research in Mental Health (CIBERSAM), Sevilla, Spain
Javier Vázquez-Bourgon
bSpanish Network for Research in Mental Health (CIBERSAM), Sevilla, Spain
dDepartment of Psychiatry, University Hospital Marques de Valdecilla - Instituto de Investigacion Marques de Valdecilla (IDIVAL), Santander, Spain
eDepartment of Medicine and Psychiatry, School of Medicine, University of Cantabria, Santander, Spain
Ana C. Sánchez-Hidalgo
bSpanish Network for Research in Mental Health (CIBERSAM), Sevilla, Spain
cSeville Biomedical Research Centre (IBiS), Sevilla, Spain
Nathalia Garrido-Torres
aDepartment of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain
Jose M. Cisneros
fDepartment of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocio, University of Seville, Spain
Carlos Prieto
gBioinformatics Service, Nucleus, University of Salamanca, Salamanca, Spain
Jesus Sainz
hSpanish National Research Council (CSIC), Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), Santander, Spain
Data Availability
The cohort to study the effect of aripiprazole on gene expression was obtained from Cantabria Biobank. The patterns of gene expression of non-COVID and COVID were obtained from CRA002390 project in GSA database
Posted December 13, 2020.
Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis
Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, Carlos Prieto, Jesus Sainz
medRxiv 2020.12.05.20244590; doi: https://doi.org/10.1101/2020.12.05.20244590
Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis
Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, Carlos Prieto, Jesus Sainz
medRxiv 2020.12.05.20244590; doi: https://doi.org/10.1101/2020.12.05.20244590
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3625)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2330)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)